(Total Views: 361)
Posted On: 08/28/2020 6:47:12 PM
Post# of 36519
I saw remdesivir got EUA for mild-moderate. Leronlimab's data is better but being phase 2, the FDA will probably require a phase 3.
Hopefully the severe interim phase 3 analysis is great.
Hopefully the severe interim phase 3 analysis is great.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)